Comparing heart signals during a new pacing device implantation
Comparative Study of the Surface and Endocavitary Signals of Cardiac Pacing System Analyzers With Respect to the Conventional Polygraphy Systems Signals During Implantation of Conduction System Pacing Devices
This study is testing if a new type of heart device can provide better signals during implantation compared to traditional methods for patients getting left bundle branch area pacing.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 78 (estimated) |
| Ages | 18 Years to 99 Years |
| Sex | All |
| Sponsor | Parc de Salut Mar Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Barcelona, Cataluña) |
| Trial ID | NCT06371846 on ClinicalTrials.gov |
What this trial studies
This observational study aims to evaluate the effectiveness of surface electrocardiogram signals obtained from different cardiac pacing analyzers during the implantation of left bundle branch area pacing (LBBAP) devices. It will compare the signals from Pacing System Analyzers (PSAs) with those from conventional multichannel polygraph systems (MPSs) in patients undergoing LBBAP as a first-line treatment. The study will collect data on procedural times, radiation exposure, and pacing parameters to determine the reliability of PSAs in this context.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years old who are scheduled to undergo LBBAP as their first pacing strategy.
Not a fit: Patients who are not undergoing LBBAP or are under 18 years of age may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the accuracy and safety of pacing device implantation, leading to better patient outcomes.
How similar studies have performed: While this approach is relatively novel, previous studies have shown promise in using advanced signal analysis for pacing procedures.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patients over 18 years of age who underwent a LBBAP system as first intention. Exclusion Criteria: * None
Where this trial is running
Barcelona, Cataluña
- Jesus Jiménez López — Barcelona, Cataluña, Spain (Recruiting)
Study contacts
- Principal investigator: Jesus Jiménez López, MD — Cardiac Electrophysiologist
- Study coordinator: Jesus Jiménez López, MD
- Email: jejilo78@gmail.com
- Phone: 680714927
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.